Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
about
Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogsPharmacokinetics of caspofungin acetate to guide optimal dosing in cats.Multilocus variable-number tandem-repeat analysis of clinical isolates of Aspergillus flavus from Iran reveals the first cases of Aspergillus minisclerotigenes associated with human infection.Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species.Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.Identification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum.Design, synthesis, and biological evaluation of aminothiazole derivatives against the fungal pathogens Histoplasma capsulatum and Cryptococcus neoformansMolecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typingPrevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaAntifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, JapanCryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)Screening and Characterization of a Non-cyp51A Mutation in an Aspergillus fumigatus cox10 Strain Conferring Azole Resistance.Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion MethodThe evolving role of antifungal susceptibility testing.Current status of antifungal resistance and its impact on clinical practice.Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.The future of fungal susceptibility testing.Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard.One-health pathogens in the Aspergillus viridinutans complex.Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.Antifungal susceptibility of 175 Aspergillus isolates from various clinical and environmental sources.Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia.Preparation and application of collagen scaffold-encapsulated silver nanoparticles and bone morphogenetic protein 2 for enhancing the repair of infected bone.Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methodsEpidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates.High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea.Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran.MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method.Evaluation of Etest performed in Mueller-Hinton agar supplemented with glucose for antifungal susceptibility testing of clinical isolates of filamentous fungi.Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins
P2860
Q21133504-37CA675D-5C90-46B2-91EA-B1E86DA1F0A7Q33757912-74B5FDEA-CAB2-41FE-9173-BA1BB6ADE206Q33905034-2D90F1D9-F01D-45EB-A6B4-5C8156994E25Q34246802-83FE382F-59F7-4DD0-9AE3-409EE7E3CAD2Q34621506-C73B4F2B-8D69-4A89-AECC-6544B9F8400BQ34788828-2ECC6B51-6FEB-4C81-9654-0FF27F70941AQ34996002-11823BA1-8540-44CC-8C98-5B1C1F833F3FQ35579694-487A40C9-2E85-498E-A3C6-FA7DD4CFFA7AQ35585364-DBD64BA4-9E23-4A33-9765-86CA45E76C69Q35666518-8308659A-18E9-4793-B2E3-364F37045867Q36018713-BB6D6E9E-6C6C-4892-A66B-73932E2E449CQ36158263-B375AA48-2436-4657-9DE2-1E516C105494Q36364064-0EECE53C-FAFB-4BA6-B0DD-F2C64BBDBF5BQ36898053-E214F7E0-947C-4897-9726-1898EC712EEDQ37538667-B4C99B93-4FE1-452E-840C-557EE09F9829Q37538775-C333FE2D-6E6A-43E7-A9EE-087F5135A91DQ38095809-58FBEFBE-AE58-43A4-B334-5AA7C899785BQ38205859-D44DC0BF-2A1C-41B9-B745-8DD33CD5E075Q38222570-10C824D1-E099-4783-ABC8-D3B5947EA72EQ38258833-1DF81CC8-DDCD-40E0-8CF9-C70937D22BE7Q38586680-EFCC1DE8-080E-444B-A453-2F4A251080F4Q38726054-796EE8A6-7F02-4FEF-8BB2-BF71944F2FA3Q38959280-C9F80003-FD4E-4DE5-A080-441A1D90CA03Q39221749-8179AFAE-F247-4BEB-975D-9F09A6295DB4Q39504883-1C5C374D-6E47-405F-BB98-ABE6AFECBFA3Q39796605-F00674C7-10BB-47B4-B1DD-AB38369DCB12Q40283086-E3DCAF21-6660-43D8-A793-A6D6B1CF4989Q41282603-575F2A1E-1DD6-49A7-9C3C-C8FD4343ECF4Q41696878-63355519-2E63-4EAC-88A1-0AD6133279B6Q41771784-21BBA0AC-29C4-4AB2-A457-4288C7F1D751Q42076268-216A2372-33FB-4B5E-B965-0B3045772BEEQ42151667-46B49BC1-9620-470D-ADC2-3A2ABFBA11A0Q42191165-5059B7FA-8807-4A9F-B3DB-8EDE970C527AQ42277564-B0485629-60C8-4534-AF1B-C01D6C5354C4Q46276204-6A79485C-62C4-4386-995A-9AA9A4E65366Q46290816-FC605DD8-EFA4-45CB-A7A2-BC57FB8CF187Q47611337-60405B53-B5A6-4AF8-AC55-09833DE3BB4CQ49679755-9363C7F7-55DF-4232-9139-9FBCCD966BDAQ50718095-37CAE7F9-A237-4C9D-8C65-EFB778E9BD76Q57746174-BB76E8D7-3313-4614-8C47-84FBD6C8B94F
P2860
Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Wild-type MIC distributions an ...... tion method (M38-A2 document).
@en
Wild-type MIC distributions an ...... LSI broth microdilution method
@nl
type
label
Wild-type MIC distributions an ...... tion method (M38-A2 document).
@en
Wild-type MIC distributions an ...... LSI broth microdilution method
@nl
prefLabel
Wild-type MIC distributions an ...... tion method (M38-A2 document).
@en
Wild-type MIC distributions an ...... LSI broth microdilution method
@nl
P2093
P2860
P356
P1476
Wild-type MIC distributions an ...... tion method (M38-A2 document).
@en
P2093
A Espinel-Ingroff
A Fothergill
J Turnidge
P2860
P304
P356
10.1128/AAC.01730-10
P407
P577
2011-03-21T00:00:00Z